Myeloproliferative Neoplasms

Pruritus May Mark Severe Symptomology in Myeloproliferative Neoplasms

By

Jessica Nye, PhD

Publish Date April 24, 2023

Researchers assessed clinical incidence of pruritus in patients with myeloproliferative neoplasms.

Hydroxyurea Does Not Appear to Increase Second Malignancy Risk in Myeloproliferative Neoplasms

By

Jonathan Goodman, MPhil

Publish Date March 30, 2023

Researchers sought to determine whether treatment with hydroxyurea for patients with MPNs would lead to a higher risk of secondary malignancies.

Update on Therapeutic Options for Myelofibrosis

By

Sara M. Tinsley-Vance, PhD, APRN, AOCN

Publish Date March 19, 2023

A review of myelofibrosis, including an update on treatment options, was presented at the 2023 ONA Summit.

Momelotinib Found Superior to Danazol for the Treatment of Myelofibrosis

By

Jennifer Larson

Publish Date February 13, 2023

Researchers sought to determine if momelotinib provided better improvements in anemia in patients with myelofibrosis, compared with treatment with danazol.

Associations of Mutations in Spliceosome Genes With Ring Sideroblasts Verified in Myelodysplastic Syndromes

By

Lauren Dembeck, PhD

Publish Date January 4, 2023

Researchers sought to verify the association of mutations in the splicing pathway gene SF3B1 with low bone marrow blast counts and increased ring sideroblasts in MDS.